Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial

被引：0
作者：
Ferguson, G. T. [1 ]
Rabe, K. F. [2 ,3 ,4 ]
Martinez, F. J.
Wang, C. [5 ]
Singh, D. [6 ,7 ]
Wedzicha, J. [8 ]
Trivedi, R. [9 ]
Rose, E. [9 ]
Ballal, S. [9 ]
McLaren, J. [9 ]
Darken, P. [9 ]
Aurivillius, M. [9 ]
Reisner, C. [9 ]
Dorinsky, P. [9 ]
机构：
[1] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[2] Lungenclin Grosshansdorf GmbH, Grosshansdorf, Germany
[3] Zentrum Pneumol & Thoraxchirurg, Grosshansdorf, Germany
[4] Deutsch Zentrum Lungenforsch DZL, Airway Res Ctr North Arcn, Neuherberg, Germany
[5] China Japan Friendship Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[6] Med Evaluat Unit Ltd, Manchester, Lancs, England
[7] Univ Manchester, Manchester, Lancs, England
[8] Imperial Coll London, Natl Herz & Lungeninst, London, England
[9] AstraZeneca, Cambridge, England
来源：
PNEUMOLOGIE | 2021年 / 75卷
关键词：
D O I：
10.1055/s-0041-1723287
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] Bone Mineral Density and Ocular Safety After 52 Weeks' Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Using Co-Suspension Delivery Technology in COPD
    Kerwin, E. M.
    Ferguson, G. T.
    Mo, M.
    DeAngelis, K.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [32] Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPD
    Tronde, Ann
    Gillen, Michael
    Borgstrom, Lars
    Lotvall, Jan
    Ankerst, Jaro
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (11) : 1300 - 1308
  • [33] Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma
    Spector, Sheldon L.
    Martin, Ubaldo J.
    Uryniak, Tom
    O'Brien, Christopher D.
    JOURNAL OF ASTHMA, 2012, 49 (01) : 70 - 77
  • [34] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Moderate Chronic Obstructive Pulmonary Disease in the ETHOS Study
    Ferguson, G. T.
    Rabe, K. F.
    Singh, D.
    Jenkins, M.
    Patel, M.
    Aurivillius, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [35] A 12-52 Week (Variable Length) Randomized Double-Blind Study of Budesonide/Formoterol Fumarate Metered Dose Inhaler (BFF MDI) Compared with Formoterol Fumarate (FF) MDI in COPD (SOPHOS)
    Hanania, N. A.
    Papi, A.
    Anzueto, A.
    Martinez, F. J.
    Rossman, K.
    Cappelletti, C.
    Duncan, E. A.
    Nyberg, J.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [36] EFFICACY AND SAFETY OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE METERED DOSE INHALER (GFF MDI) DELIVERED USING CO-SUSPENSION DELIVERY TECHNOLOGY IN CHINESE PATIENTS WITH COPD
    Zhong, Nanshan
    Chen, Rongchang
    Wang, Hao-Yan
    Zhao, Li
    Mei, Xiaodong
    Qin, Zhiqiang
    Assam, Pryseley N.
    Maes, Andrea
    Martin, Ubaldo J.
    Reisner, Colin
    RESPIROLOGY, 2018, 23 : 81 - 81
  • [37] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
    Ferguson, Gary T.
    Darken, Patrick
    Ballal, Shaila
    Siddiqui, Mohd Kashif
    Singh, Barinder
    Attri, Sumeet
    Holmgren, Ulf
    de Nigris, Enrico
    ADVANCES IN THERAPY, 2020, 37 (06) : 2956 - 2975
  • [38] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
    Gary T. Ferguson
    Patrick Darken
    Shaila Ballal
    Mohd Kashif Siddiqui
    Barinder Singh
    Sumeet Attri
    Ulf Holmgren
    Enrico de Nigris
    Advances in Therapy, 2020, 37 : 2956 - 2975
  • [39] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
    Chen Wang
    Ting Yang
    Jian Kang
    Rongchang Chen
    Li Zhao
    Huijie He
    Pryseley N. Assam
    Rong Su
    Eric Bourne
    Shaila Ballal
    Kiernan DeAngelis
    Paul Dorinsky
    Advances in Therapy, 2020, 37 : 1591 - 1607
  • [40] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
    Wang, Chen
    Yang, Ting
    Kang, Jian
    Chen, Rongchang
    Zhao, Li
    He, Huijie
    Assam, Pryseley N.
    Su, Rong
    Bourne, Eric
    Ballal, Shaila
    DeAngelis, Kiernan
    Dorinsky, Paul
    ADVANCES IN THERAPY, 2020, 37 (04) : 1591 - 1607
12345